Literature DB >> 8148367

4-Ethoxyamphetamine: effects on intracranial self-stimulation and in vitro uptake and release of 3H-dopamine and 3H-serotonin in the brains of rats.

K M Hegadoren1, A J Greenshaw, G B Baker, M T Martin-Iverson, B Lodge, S Soin.   

Abstract

Experiments were conducted to compare the effects of 4-ethoxyamphetamine, a novel "designer" amphetamine, with (+)-amphetamine and an earlier "designer" amphetamine, 4-methoxyamphetamine, on rats. (+)-Amphetamine significantly decreased frequency threshold measures in an intracranial self-stimulation (ICSS) procedure using medial forebrain bundle electrodes, while 4-methoxyamphetamine and 4-ethoxyamphetamine increased these ICSS frequency thresholds. 4-Methoxyamphetamine and 4-ethoxyamphetamine had more potent effects on inhibition of uptake and stimulation of spontaneous release of 5-hydroxytryptamine (serotonin) than of dopamine. It is concluded that the neuropsychopharmacological profile of 4-ethoxyamphetamine is unlike that of (+)-amphetamine, but similar to that of 4-methoxyamphetamine, a potent hallucinogen in humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8148367      PMCID: PMC1188563     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  19 in total

1.  Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine.

Authors:  M Raiteri; F Cerrito; A M Cervoni; G Levi
Journal:  J Pharmacol Exp Ther       Date:  1979-02       Impact factor: 4.030

Review 2.  Enantioselective aspects of drug action and disposition: therapeutic pitfalls.

Authors:  F Jamali; R Mehvar; F M Pasutto
Journal:  J Pharm Sci       Date:  1989-09       Impact factor: 3.534

3.  The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine.

Authors:  E B Arnold; P B Molinoff; C O Rutledge
Journal:  J Pharmacol Exp Ther       Date:  1977-09       Impact factor: 4.030

4.  d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.

Authors:  M Raiteri; A Bertollini; F Angelini; G Levi
Journal:  Eur J Pharmacol       Date:  1975-11       Impact factor: 4.432

5.  A behavioural and neurochemical analysis of chronic and selective monoamine oxidase inhibition.

Authors:  D O'Regan; R P Kwok; P H Yu; B A Bailey; A J Greenshaw; A A Boulton
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis.

Authors:  B H Westerink; R M Hofsteede; J Tuntler; J B de Vries
Journal:  J Neurochem       Date:  1989-03       Impact factor: 5.372

7.  Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine.

Authors:  H H Miller; P A Shore
Journal:  Eur J Pharmacol       Date:  1982-02-19       Impact factor: 4.432

8.  Pimozide and amphetamine have opposing effects on the reward summation function.

Authors:  C R Gallistel; D Karras
Journal:  Pharmacol Biochem Behav       Date:  1984-01       Impact factor: 3.533

9.  The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward.

Authors:  C B Hubner; M Bird; S Rassnick; C Kornetsky
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 10.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

View more
  2 in total

1.  Dexamphetamine effects on separate constructs in the rubber hand illusion test.

Authors:  Matthew A Albrecht; Mathew T Martin-Iverson; Greg Price; Joseph Lee; Rajan Iyyalol; Flavie Waters
Journal:  Psychopharmacology (Berl)       Date:  2011-03-23       Impact factor: 4.530

2.  Pharmacological Characterization of 4-Methylthioamphetamine Derivatives.

Authors:  Fabrizzio G Guajardo; Victoria B Velásquez; Daniela Raby; Gabriel Núñez-Vivanco; Patricio Iturriaga-Vásquez; Rodrigo A España; Miguel Reyes-Parada; Ramón Sotomayor-Zárate
Journal:  Molecules       Date:  2020-11-13       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.